Heart Test Laboratories Overview
Heart Test Laboratories (HSCS) has a ROE of 101443.94%, above the sector sector average of -5.84%.
Get informed when a big investor buys or sells
+ Follow101443.94%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Heart Test Laboratories (HSCS) currently reports a ROE of 101443.94%. That is above the sector sector average of -5.84%. Use the charts on this page to explore Heart Test Laboratories's ROE history and peer comparisons.
Heart Test Laboratories's ROE of 101443.94% is higher than the its sector sector average of -5.84%. That is roughly 1735695.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Heart Test Laboratories's current 101443.94% should be judged against industry norms (sector average: -5.84%) and against HSCS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 101443.94%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.84%. From there, open related valuation or income-statement pages for Heart Test Laboratories, and consider following HSCS for alerts when major investors trade the stock.
